Catheter Precision, Inc. Receives Notice of First Patent Allowance in the US for LockeT Product Line

NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced that it has received a notice of allowance from the US Patent Office of its first patent in the US for its LockeT product, filed in December 2022, for its design of a surgical closure device for orthoscopic entry wounds. David Jenkins, CEO of Catheter Precision, commented, "This first US patent for LockeT joins our other issued international LockeT pate ...